Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

KITTEE TRC20 Token Ad

BCRX Quote Trading Chart BioCryst Pharmaceuticals Inc.


home / stock / bcrx / bcrx quote

$14.64 Last:

32.85% Change Percent:

$14.6 Open:

$11.02 Previous Close:

$14.86 High:

$14.44 Low:

2,788,600 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

BCRX Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-08-1214.611.0214.8614.442,788,600
2022-08-1114.7911.0214.9714.22383,294,804
2022-08-1014.6911.0214.8914.5252,004,030
2022-08-0914.111.0214.7113.793,504,571
2022-08-0813.9711.0215.4313.94,674,419
2022-08-0512.9311.0214.3212.886,070,008
2022-08-0412.7111.0214.1912.3511,711,919
2022-08-0311.2911.0211.749211.023,173,509
2022-08-0210.7811.0211.14510.71,486,136
2022-08-0110.9111.0211.210.7751,812,136
2022-07-2910.9311.0211.0710.651,812,397
2022-07-2811.0211.0211.0910.641,344,198
2022-07-2610.7610.7611.0410.56855,371
2022-07-2511.210.911.210.821,930,838
2022-07-1911.5411.8311.93511.542,058,678
2022-07-1811.8311.3612.0211.282,260,997
2022-07-1511.6611.6511.6811.1653,435,429
2022-07-1411.8811.4911.9911.422,944,779
2022-07-1311.0611.9712.0310.962,943,497
2022-07-1211.0911.2411.4410.8652,994,906
Stock Information

BioCryst Pharmaceuticals Inc. Company Name:

BCRX Stock Symbol:

NASDAQ Market:

BioCryst Pharmaceuticals Inc. Website:

BCRX Quote Trading Chart BioCryst Pharmaceuticals Inc.

MENU
BCRX BCRX Quote BCRX Short BCRX News BCRX Articles BCRX Message Board
Get BCRX Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

KITTEE TRC20 Token Ad
RECENT BCRX NEWS
  • BCRX - BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript

    Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX) Q2 2022 Earnings Call Aug 04, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript ...

  • BCRX - Why BioCryst Pharmaceuticals Stock Is Bolting Higher Today

    Shares of the rare disease specialist BioCryst Pharmaceuticals (NASDAQ: BCRX) were up by a noteworthy 20% on heavy volume at 9:38 a.m. ET Thursday morning. Although the biotech reported encouraging 2022 second-quarter results prior to today's opening bell, the real needle mover ...

  • BCRX - BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones

    —Q2 2022 ORLADEYO net revenue of $65.2 million— —FY 2022 ORLADEYO net revenue expected to be between $255 million and $265 million— RESEARCH TRIANGLE PARK, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.



Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News